BackDeep Medicine Acquisition Overview

Deep Medicine Acquisition Long Term Debt

Track Deep Medicine Acquisition's long-term debt ($160K) with charts, peers, and YoY trends.

Get informed when a big investor buys or sells

+ Follow
Long Term Debt
$164664.00
↓ 97.29% YoYΔ $-5.91M vs prior year quarter

Peer average / median

Loading

Deep Medicine Acquisition Long Term Debt History

Loading

Deep Medicine Acquisition vs. peers: Long Term Debt Comparison

Loading

Deep Medicine Acquisition Long Term Debt Growth (YoY per quarter)

Latest change versus the prior comparable period (same company).

Loading

Balance Sheet Breakdown

Current CashShort Term InvestmentsReceivablesInventoryOther Current AssetsCurrent AssetsLong Term InvestmentsProperty Plant EquipmentGoodwillIntangible AssetsOther AssetsTotal AssetsNet Tangible AssetsAccounts PayableOther Current LiabilitiesTotal Current LiabilitiesLong Term DebtOther LiabilitiesMinority InterestTotal Liabilities

Deep Medicine Acquisition (DMAQ) FAQ

Deep Medicine Acquisition (DMAQ) currently reports a long-term debt of $160K as of March 2026. That compares with $6.1M in the prior-year period — down 97.3% year over year. Use the charts on this page to explore Deep Medicine Acquisition's long-term debt history and peer comparisons.

Deep Medicine Acquisition's long-term debt decreased from $6.1M to $160K — a 97.3% year-over-year decrease (period ending March 2026). Watching multi-year history on the chart below helps separate one-off swings from a lasting trend.

Deep Medicine Acquisition reported $160K in long-term debt as of March 2026. That compares with $6.1M in the prior-year period — down 97.3% year over year. Absolute dollar amounts are most useful when compared with prior periods, peers, and related line items such as revenue, assets, or liabilities on Stockcircle.

Start with the current long-term debt of $160K, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Deep Medicine Acquisition, and consider following DMAQ for alerts when major investors trade the stock.